Compare BCPC & CHH Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | BCPC | CHH |
|---|---|---|
| Founded | 1967 | 1939 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Major Chemicals | Hotels/Resorts |
| Sector | Industrials | Consumer Discretionary |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 5.8B | 5.1B |
| IPO Year | 1995 | 1997 |
| Metric | BCPC | CHH |
|---|---|---|
| Price | $169.19 | $95.43 |
| Analyst Decision | Buy | Hold |
| Analyst Count | 2 | 13 |
| Target Price | ★ $176.00 | $112.92 |
| AVG Volume (30 Days) | 139.9K | ★ 558.3K |
| Earning Date | 05-25-2026 | 05-21-2026 |
| Dividend Yield | 0.56% | ★ 1.20% |
| EPS Growth | 20.87 | ★ 27.42 |
| EPS | 4.75 | ★ 7.90 |
| Revenue | $799,023,000.00 | ★ $1,596,793,000.00 |
| Revenue This Year | $8.28 | $66.94 |
| Revenue Next Year | $4.90 | $0.43 |
| P/E Ratio | $35.87 | ★ $12.13 |
| Revenue Growth | ★ 13.56 | 0.75 |
| 52 Week Low | $139.17 | $84.04 |
| 52 Week High | $183.90 | $136.45 |
| Indicator | BCPC | CHH |
|---|---|---|
| Relative Strength Index (RSI) | 40.33 | 36.11 |
| Support Level | $165.89 | $92.10 |
| Resistance Level | $170.35 | $100.40 |
| Average True Range (ATR) | 4.85 | 3.78 |
| MACD | -1.68 | -1.37 |
| Stochastic Oscillator | 10.91 | 13.64 |
Balchem Corp is engaged in the development, manufacture, and marketing of specialty performance ingredients and products for various industries. The company's reportable segments are; Human Nutrition and Health, which generates maximum revenue, and provides human-grade choline nutrients and mineral amino acid chelated products through this segment for nutrition and health applications; Animal Nutrition and Health, which provides nutritional products derived from its microencapsulation and chelation technologies in addition to the essential nutrient choline chloride; and the Specialty Products segment includes re-packaging and distributing several performance gases and chemicals. Geographically, the company derives its key revenue from the United States and the rest from foreign countries.
At year-end 2024, Choice Hotels operated 654,000 rooms across the economy, midscale, upscale, and extended-stay segments. Comfort Inn and Comfort Suites are the largest brands (26% of the company's total domestic rooms), while Ascend and Cambria (10%) are newer lifestyle and select-service brands. Choice closed on its Radisson acquisition in August 2022, which added about 70,000 rooms. Franchises account for 100% of total revenue, and the United States represented 78% of total rooms in 2024.